Content of matrix metalloproteinases in the blood of hypertensive patients with a high cardiovascular risk receiving statin therapy

Content of matrix metalloproteinases in the blood of hypertensive patients with a high cardiovascular risk receiving statin therapy

Aim. To compare the effect of atorvastatin and rosuvastatin as part of complex therapy in patients with hypertension (HTN) with a high cardiovascular risk on the level of matrix metalloproteinases -1, -9 (MMP-1, MMP-9) and tissue inhibitors of metalloproteinases -1, -4 (TIMP-1, TIMP-4).Material and...

Full description

Saved in:
Bibliographic Details
Main Authors: V. P. Mikhin, O. A. Osipova, V. V. Vorotyntseva, D. N. Perutsky, N. I. Golovina
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 2022-11-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
hypertension
cardiovascular risk
statins
matrix metalloproteinases
tissue inhibitors of metalloproteinases
Online Access:https://cardiovascular.elpub.ru/jour/article/view/3422
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items